Who is sponsoring NCT03922399?

NCT03922399 is sponsored by Shin Kong Wu Ho-Su Memorial Hospital.

What drugs are being tested in NCT03922399?

Interventions in NCT03922399: Laser and Surgery.

What condition does NCT03922399 study?

NCT03922399 studies Patients With Major Burn Injury in Formosa FunCost Explosion.

Is NCT03922399 still recruiting?

NCT03922399 is currently completed. Last updated 22 April 2019.

Last reviewed 2019-04-22 · How we verify

NCT03922399

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcome Evaluation for Burn Scar Therapy-laser and Surgery in Patients in Formosa Fun Coast Explosion

Completed NA Last updated 22 April 2019

What this trial tests

NA trial testing Laser and Surgery in Patients With Major Burn Injury in Formosa FunCost Explosion in 8 participants. Completed in 8 March 2019.

Timeline

1 October 2018

Primary endpoint
27 January 2019

8 March 2019

Quick facts

Lead sponsor	Shin Kong Wu Ho-Su Memorial Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	8
Start date	1 October 2018
Primary completion	27 January 2019
Estimated completion	8 March 2019
Sites	1 location across Taiwan

Drugs / interventions tested

Laser and Surgery

Conditions studied

Patients With Major Burn Injury in Formosa FunCost Explosion — all drugs for Patients With Major Burn Injury in Formosa FunCost Explosion →

Sponsor

Shin Kong Wu Ho-Su Memorial Hospital

Who can join

20 and older, any sex, with Patients With Major Burn Injury in Formosa FunCost Explosion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Protocol title： Outcome evaluation for burn scar therapy-laser and surgery in patients in Formosa Fun Coast Explosion Objectives： The goal of this study is to evaluate the effectiveness of both lasers and operations on patients with major burn scar(\>20% TBSA).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Shin Kong Wu Ho-Su Memorial Hospital trials

Trials by the same sponsor.

NCT07324005 — Efficacy of Combining Ultrasound-Guided Needle Release of Transverse Carpal Ligament and Median Nerve Dextrose Water Hyd · NA · not yet recruiting
NCT07207356 — Ultrasound Guided Transcutaneous Pulsed Radiofrequency for Cervical Radiculopathy · NA · recruiting
NCT07032051 — Continuous Passive Motion to Prevent Ankle Contracture and Muscle Atrophy in Ventilated Patients · NA · not yet recruiting
NCT06935877 — Additional Effect of Steroid on Hyaluronic Acid in Subdeltoid Bursitis · Phase 4 · not yet recruiting
NCT06702046 — The Efficacy of Transcutaneous Pulsed Radiofrequency Acupuncture for Knee Osteoarthritis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03922399 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shin Kong Wu Ho-Su Memorial Hospital
Last refreshed: 22 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03922399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing